Construction of plasmids and in vitro expression analysis of the N and potential I genes. For in vitro expression analysis of the N and potential I genes from the same synthetic mRNA molecule, capped transcripts having the leader and body sequence of the N mRNA were generated in vitro and translated in wheat germ lysate. Plasmid pSP6LN was used in all experiments in which the N gene was analyzed (Fig. 2) . Transcripts of plasmid did not totally mimic intracellular N mRNA structure, however, since the 5' terminus of the leader was incomplete and the poly(A) tail along with the first 82 nucleotides (nt) of the 3' noncoding region were missing. We have recently determined the 5' leader on the BCV N mRNA to be 5'-GAUUGUGAGCGAUUUGCGUG CGUGCAUCCCGCUUCACUGAUCUCUUGUUAGAUC UUUUUAUAAUCUAAACUUUAAGGAUG (GenBank accession number M62375 [21a]), in which nt 63 is the point of divergence between the genome and the leader sequence and the underlined AUG is the initiator codon for N. In the pSP6LN construct, the 5' seven nucleotides of the leader (GAUUGUG) were replaced by the sequence 5' cggaauucgguaccuUUGCG, in which the first 15 nt (lowercase) provided EcoRI and Kjpnl restriction endonuclease sites and the UUGCG (uppercase) was our perception of the leader 5' end at the time the construct was made. pSP6LN was constructed in three steps. (i) The BCV leader sequence was cloned by amplifying an extended primer from the 5' end of the N mRNA by the polymerase chain reaction (PCR) and cloning the amplified fragment into pGEM3Z (Promega). Primers used for PCR were 5'-CCAG AACGAT7FICCAAAGGACGCTCT-3' (primer 1), which anneals to nt 31 through 56 downstream from the start codon 5277
) (32) . An internal ORF of identical size and nearly identical position was found within the N gene of the antigenically related mouse hepatitis virus strain A59 (5) . Except for one interrupting point mutation in the N gene of mouse hepatitis virus strain JHM (AAA--UAA at amino acid 17 in comparison with BCV) (46) and two in the N gene of human coronavirus strain OC43 (AUG-AUC and CAG--UAG at amino acids 1 and 61, respectively, in comparison with BCV) (24) , internal ORFs of identical size were found in these antigenically related viruses as well. No such internal ORFs were found, however, in the N genes of the more distantly related avian infectious bronchitis virus (7) , porcine transmissible gastroenteritis virus (25) , feline infectious peritonitis virus (12) , and human coronavirus 229E (43) .
Because the internal ORF is conserved in size between BCV and mouse hepatitis virus A59, and a significant (45%) amino acid sequence identity is also found between their putative I proteins, we initiated experiments to determine whether the I protein is produced during virus replication and, if so, to determine how it is generated and what its intracellular location might be. For in vitro expression of only the internal ORF, plasmid pSP6I was prepared as described in step (iii) above except that only the XmnI-EcoRI fragment of clone pBMN ( Fig.  2A ) and the SmaI-EcoRI-linearized, dephosphorylated pGEM3Z vector were used in a two-way ligation reaction.
For preparation of transcripts for in vitro translation, plasmids pSP6LN and pSP6I were linearized with EcoRI and transcribed with SP6 RNA polymerase.
Sequencing analyses used to seek evidence of edited mRNA molecules. For sequencing of extended primers prepared from bulk N mRNA, cytoplasmic RNA was extracted from infected cells at 6 h postinfection as previously described (22), and 5'-end-labeled primer 1 was annealed and extended with reverse transcriptase, purified, and sequenced by the method of Maxam and Gilbert (38) as previously described (44) .
For dideoxynucleotide termination sequencing of asymmetrically amplified cDNA of the N mRNA 5' end, cytoplasmic RNA from infected cells was first used to prepare single-stranded cDNA by priming the reaction with primer 3
[5'-GGGGGGGGGGACGCG'1'1H1'1'1'1'1'1'1'1'-3'; a primer which contains an MIuI site and primes within the poly(A) tail] and extending it with reverse transcriptase, using conditions that we have previously described (21) . The N mRNA cDNA was amplified symmetrically with 30 cycles of PCR using primers 2 and 3, and the N mRNA-length product was purified by agarose gel electrophoresis and electroeluted by standard procedures (21, 42) . From this, a portion was used to inoculate a 60-cycle asymmetric PCR in which primer 2 was the limiting primer and either primer 1 or primer 4 (5'-GTCCCGATCGAGAATGTCAGCCGGGG-3'; a primer which binds to nt 409 through 434 downstream from the start of the I gene) was the nonlimiting primer. Asymmetric PCR and dideoxynucleotide termination sequencing with 5'-end-labeled primer 2 were performed as previously described (20) .
Preparation of rabbit antipeptide serum. A synthetic peptide of 21 amino acids (NH2-KKERSLNLQRDKVCLL HQESQ-COOH) representing amino acid positions 53 through 73, a hydrophilic region of the I protein (Fig. iB) , was synthesized. One milligram was suspended in 1 ml of water, emulsified with an equal volume of Freund's complete adjuvant and 0.2 mg of N-acetylmuramyl-L-alanyl-Disoglutamine (Calbiochem-Behring), and injected subcutaneously at eight sites over the back and sides of a 2-month-old rabbit. The rabbit was boosted three times at 2-week intervals by similarly injecting 1 mg of peptide emulsified in Freund's incomplete adjuvant, and the rabbit was bled 2 weeks after the last boost.
Analysis of the N and I proteins synthesized in vitro. For analysis of radiolabeled proteins synthesized in vitro, ap- was used per 50-,ul translation reaction volume as described by Anderson and Blobel (4). When rabbit serum was used, Sephadex-conjugated staphylococcal protein A was used to concentrate the antigen-antibody complex; when bovine serum was used, Sephadex-conjugated staphylococcal protein G was used. Radiolabeled proteins were analyzed by electrophoresis in gels of 10% polyacrylamide by the method of Laemmli (31) and were analyzed as previously described (32) . For quantitation, dried gels were scanned with the Ambis Radioanalytic Imaging System (Ambis, San Diego, Calif.). '4C-labeled molecular weight marker proteins were myosin (200 kDa), phosphorylase b (92.5 kDa), bovine serum albumin (69 kDa), soybean trypsin inhibitor (21.5 kDa), and lysozyme (14.3 kDa) (Amersham) and were included in all gels for protein analysis. For analyzing membrane association and translocation, proteins were synthesized in the presence of canine pancreatic microsomes (Promega) by the method of Walter and Blobel (50) . Removal by washing in the presence of EDTA and measurement of resistance to trypsin digestion were done by the method of Morimoto et al. (39) , and membrane association by extraction at pH 11 was done by the method of Fujiki et al. (14) . 
RESULTS
The I protein is made during virus replication and becomes membrane associated. In vivo labeling and RNA hybridization experiments have identified the N mRNA as the smallest of the 3' coterminal mRNAs for BCV (22) , suggesting that if the I protein is made, it is synthesized from the N mRNA species. To test whether the N mRNA can serve as a template for synthesis of I, SP6 RNA polymerase-generated transcripts of plasmid pSP6LN were translated in vitro. In addition to N, which represented 43% of the product synthesized, a protein the predicted size of 1(23 kDa) which represented 12% of the total product was also made (Fig. 2B,  lane 1) . The 23-kDa protein species synthesized from the pSP6LN transcript migrated with the same mobility as did the major product from the pSP6I transcript on which I synthesis begins at the first available methionine codon (Fig.  2B, lane 2) . Transcripts from a modified pSP6LN construct in which the predicted I initiator codon had been destroyed by mutagenesis failed to make the 23-kDa protein, thus confirming this codon as the start of I synthesis (data not shown). In addition to N and the 23-kDa protein, three other proteins intermediate in size between N and the 23-kDa species were produced from the pSP6LN transcript, and together these represented approximately 45% of the total product (Fig. 2B, lane 1) . These proteins apparently are products of premature termination of N translation or translation products of prematurely terminated transcripts, since all three of the proteins intermediate in size between N and the 23-kDa species immunoprecipitated with polyclonal N-specific antiserum (data not shown). They are unlikely to be products of internal initiation on the N ORF, since the next possible start codon within the N ORF is at amino acid position 232 (32) , and this would yield a predicted protein smaller than 22 kDa.
To test whether transcripts with the precise structure of N mRNA would also synthesize the I protein, N mRNA was separately cloned from infected cells, and a clone, pLN, confirmed by sequencing to have the proper termini [i.e., a 5'-terminal GAUUGUG. . ., the N ORF, the complete 3' noncoding sequence, and a 3' poly(A) tail of 21 nt] was used to prepare transcripts for translation. The results of this translation were similar to those depicted in Fig. 2B , lane 1, except that the species between N and I were diminished in amount (representing less than 20% of the total product), and N and I represented 50 and 20%, respectively, of the product.
Three approaches were used to determine whether I is made during virus replication. In the first, the I-specific antipeptide serum was used to test for immunoprecipitation of the 23-kDa protein from infected cells. Antipeptide serum prepared in a rabbit, but not preimmune serum, immunoprecipitated I protein made in vitro (Fig. 3A, lanes 2 and 3) , thus establishing the I specificity of the antipeptide serum. The antipeptide serum but not the preimmune serum immunoprecipitated a product of the same size from infected cells (Fig.  3A , lanes 5 and 6), indicating that I is made during virus replication and probably undergoes no posttranslational modification that would alter its electrophoretic mobility, such as N-linked glycosylation at amino acid 24 or signal peptide cleavage (32) . In the second approach, hyperimmune calf serum known to immunoprecipitate N protein made in vitro (Fig. 3B, lane 2) was used to test for immunoprecipitation of I made in vitro. Hyperimmune but not preimmune calf serum immunoprecipitated I (Fig. 3B, lanes 5 and 6) , indicating that the I protein not only is made during virus infection but also induces an antibody response. In the third approach, the antipeptide serum was used to test for immunofluorescence of BCV-infected cells. Figure 4 illustrates an internal diffuse cytoplasmic fluorescence in cells fixed with ethanol (Fig. 4B ) and a surface fluorescence on cells fixed with paraformaldehyde only (Fig. 4D) . No immunofluorescence was observed when preimmune serum was used ( Fig.   4A and C) The I protein is moderately hydrophobic overall, since 79 (38%) of its amino acids are hydrophobic (32) . With some hydrophobic amino acids concentrated on the termini of the protein (Fig. 1B) , it is possible that one of the termini or both become transmembrane domains and serve to anchor I to the membrane. To test whether I associates with membranes during synthesis in vitro, transcripts of pSP6I were translated in the presence of canine pancreatic microsomes, and the association of I with pelleted microsomal membranes was examined. Figure 3C illustrates that I remains associated with pelleted membranes both before (lane 2) and after (lane 4) microsomal lysis, indicating either that there is a strong nonanchored attraction between I and the membrane or that there is anchorage as the result of partial translocation or possibly from addition of a fatty acid side chain. As with synthesis of the I protein in cells, there was no change in the electrophoretic mobility of I after synthesis in the presence of microsomes, suggesting that there is no glycosylation or signal peptide cleavage that would indicate membrane translocation.
Of the possible mechanisms for the association of the I protein with microsomes, we can rule out divalent cationmediated attraction, since washing of microsomes at pH 7 in the presence of a chelating agent (25 mM EDTA) removed only a small fraction of I from the membranes (data not shown). We cannot rule out simple hydrophobic attraction, however. Regarding the possibility of translocation, we can rule out the possibility that a majority of I had become translocated into the lumen of the microsome to become anchored as a type I membrane protein (i.e., anchored by its carboxy terminus) or as a type II membrane protein (i.e., anchored by its amino terminus), since no portion of I larger than a 12-kDa fragment could be identified by gel electrophoresis following trypsin treatment in microsomes (Fig. 3C,   lane 6) . Our experiments do not, however, rule out the possibility that only a small portion of I had become translocated, leaving a majority of the protein on the cytoplasmic surface of the microsome. Further study is required to determine the mechanism of membrane association.
An unedited mRNA is used for the expression of I. Despite the fact that I can be synthesized in vitro from the N mRNA, from precedent in other animal RNA virus systems (27, 40, (47) (48) (49) , it is possible that the N mRNA species undergoes editing in vivo to yield a subpopulation of mRNA molecules from which I is put in frame with N to yield a fusion protein.
In this molecule, the initiator codon for N would be used to synthesize I. Alternatively, the N initiator codon could be ablated by editing, leaving the I initiator codon as the first methionine codon on the transcript. The first possibility is unlikely, since I was not immunologically detected in studies using N-specific polyclonal antiserum (data not shown). Nevertheless, two experimental approaches were taken to seek evidence for either kind of mRNA editing. In the first, an oligonucleotide primer binding just downstream of the N initiator codon was 5' end labeled, extended with reverse transcriptase, and sequenced by the method of Maxam and Gilbert (38) . No ambiguity in the sequence was observed, suggesting that all or at least the vast majority of N-specific mRNA molecules are unedited (data not shown). Figure 5 shows the results of this experiment in the region of the N initiator codon and illustrates the lack of ambiguity and thus the intactness of the N initiator codon. In a second approach, single-stranded DNA molecules prepared by asymmetric PCR amplification of N mRNA cDNA were sequenced by the dideoxynucleotide chain termination method. No ambiguity in this sequence was observed regardless of whether the reaction was primed from just downstream of the N start codon (with primer 1) or from just downstream of the I start codon (with primer 4), indicating the absence of any editing between the 5' end of the mRNA and the I start codon (data not shown). In addition, no modified N initiator codons were found in any of 138 separate cDNA clones of N mRNA prepared as part of another study (21a) . DISCUSSION We have demonstrated that a large overlapping ORF located within the N gene of BCV is expressed during virus replication, resulting in the synthesis of a 23-kDa protein that we name the I (for internal ORF) protein. Our data show that I is expressed from the unedited N mRNA molecule by downstream initiation of translation. Although bicistronic mRNAs for animal RNA minus-strand viruses (myxoviruses [45] , paramyxoviruses [3, 6, 11, 15-17, 35, 37, 45] , and bunyaviruses [2] ) and double-stranded viruses (reoviruses [13] ) in which one ORF completely overlaps another have been described, to our knowledge, this is the first example of such a bicistronic mRNA for a cytoplasmically replicating, positive-strand animal RNA virus. A functional bicistronic mRNA of similar structure has recently been reported for members of the positive-strand tombusviruses of plants, however (18, 19, 41) .
The function of the I protein is not apparent, nor can it be deduced from sequence similarities to proteins of known function identified by a computer search of GenBank. Significant similarities were found with only the I homolog in the N genes of mouse hepatitis virus (45% amino acid sequence identity) and human coronavirus OC43 (91% identity). The absence of an I homolog in other coronaviruses would indicate that I does not perform a universally required function for coronavirus survival. It may, however, be critical for replication in the animal for those coronaviruses closely related to BCV, which, interestingly, happen to be those also possessing a hemagglutinin-esterase protein or a nonfunctional hemagglutinin-esterase gene (23, 26, 36, 51) . I protein function may not be required for replication in cell culture, and thus disruptions in the I genes of mouse hepatitis virus strain JHM and human coronavirus strain OC43 may have occurred during cell culture passage prior to the time of molecular cloning (24, 46) .
The mechanism by which the I protein associates with membranes is unresolved. Although we have shown that a majority of the I protein molecule probably does not translocate to become a type I or a type II membrane protein, we have not ruled out the possibility that a small portion containing the hydrophilic peptide region translocated to the luminal surface and remain anchored. Such an anchored protein would most readily explain the occurrence of some of the I protein on the cell surface. The fact that there is a diffuse distribution of the I protein throughout the cytoplasm (Fig. 4B) , however, would suggest that I, like N, is synthesized on free ribosomes in the cytoplasm. Although this pattern is inconsistent with membrane proteins that are undergoing anchorage or translocation, it does not rule out the possibility that a subpopulation of the I protein is being synthesized at the endoplasmic reticulum. Further work is needed to determine the exact nature of the membrane association of the I protein and whether it becomes part of the virion.
The question of how ribosomes access the downstream start codon of the I ORF have not been rigorously answered, but the observed pattern of I synthesis from an unedited N mRNA and the nucleotide sequence of the mRNA conform to the leaky scanning model for ribosomal accession of downstream ORFs (28, 29) . In the N mRNA molecule, the start codon for N (AGGAUGU, the first available methionine codon) is in a suboptimal context for initiation of translation, since the nucleotide at the +4 position is a pyrimidine rather than a purine and the start codon for I (GUAAUGG, the second available methionine codon), with a purine at both the -3 and +4 positions, is in an optimal context. This pattern, according to the leaky scanning model, would allow passage of some ribosomes past the first codon to initiate translation at the second.
In light of recent evidence showing internal ribosomal entry to be important for synthesis of downstream overlapping ORFs on the polycistronic paramyxovirus P mRNA (3, 9, 10, 11, 16) (8, 33-34a) , and these too appear to be translated from a single species of mRNA. In these cases, however, the overlaps are relatively short, ranging from 17 nt between the 3b and 3c protein genes in mRNA 3 of avian infectious bronchitis virus (34) 
